Total Funding
56
56
Total FundingConvertible Note raised
Growth Score 56 in past quarter
-4 pts
Heat Score 56 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
103085
PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes.
- Past Role: SwissBlot, Co-founder
- Tomas de Wouters: co-founder & CEO
About the Company
PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes. Their technology platform optimizes the lean and efficient development and production of defined, function-based microbiome therapies to treat intestinal diseases.
PharmaBiome’s proprietary development pipeline allows a fast translation from
the identification of mode of action to a product ready for clinics, using tailored, ecologically sound bacterial mixtures.